Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.420
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Akebia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 380 | 427 | 415 | 234 | 106 | 395 | |
| Market Cap Growth | -2.41% | 3.06% | 77.46% | 120.08% | -73.16% | -2.30% | |
| Enterprise Value | 394 | 460 | 484 | 301 | 121 | 363 | |
| Last Close Price | 1.42 | 1.61 | 1.90 | 1.24 | 0.58 | 2.26 | |
| Forward PE | - | 82.56 | - | - | - | - | |
| PS Ratio | 1.61 | 1.81 | 2.59 | 1.20 | 0.36 | 1.87 | |
| PB Ratio | 11.56 | 13.10 | -8.43 | -7.64 | 20.30 | 5.34 | |
| P/FCF Ratio | 5.62 | 6.31 | - | - | - | - | |
| P/OCF Ratio | 5.60 | 6.28 | - | - | - | - | |
| EV/Sales Ratio | 1.67 | 1.95 | 3.02 | 1.55 | 0.41 | 1.71 | |
| EV/EBITDA Ratio | 14.46 | 16.86 | - | - | 39.44 | - | |
| EV/EBIT Ratio | 15.17 | 17.68 | - | - | - | - | |
| EV/FCF Ratio | 5.82 | 6.79 | - | - | - | - | |
| Debt / Equity Ratio | 6.10 | 6.10 | -3.84 | -4.72 | 30.07 | 2.56 | |
| Debt / EBITDA Ratio | 6.16 | 6.16 | - | - | 18.82 | - | |
| Debt / FCF Ratio | 2.94 | 2.94 | - | - | - | - | |
| Net Debt / Equity Ratio | 0.43 | 0.43 | -2.78 | -3.31 | 12.77 | 0.53 | |
| Net Debt / EBITDA Ratio | 0.51 | 0.51 | -15.73 | -14.76 | 21.86 | -0.21 | |
| Net Debt / FCF Ratio | 0.21 | 0.21 | -3.36 | -4.33 | -0.91 | -0.15 | |
| Asset Turnover | 0.79 | 0.79 | 0.69 | 0.65 | 0.66 | 0.36 | |
| Inventory Turnover | 2.53 | 2.53 | 1.64 | 2.13 | 0.77 | 1.67 | |
| Quick Ratio | 1.42 | 1.42 | 1.07 | 0.82 | 1.01 | 0.79 | |
| Current Ratio | 1.55 | 1.55 | 1.41 | 1.18 | 1.43 | 1.04 | |
| Return on Equity (ROE) | - | - | - | - | -237.83% | -175.37% | |
| Return on Assets (ROA) | 5.44% | 5.44% | -12.49% | -9.30% | -4.89% | -24.27% | |
| Return on Capital Employed (ROCE) | 12.20% | 12.20% | -33.10% | -31.40% | -15.30% | -84.90% | |
| Earnings Yield | -1.41% | -1.25% | -16.74% | -22.23% | -88.77% | -71.32% | |
| FCF Yield | 17.80% | 15.85% | -9.82% | -10.01% | -69.03% | -63.99% | |
| Buyback Yield / Dilution | -21.91% | -21.91% | -12.53% | -2.56% | -10.14% | -19.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.